News October 24, 2014 Qiagen launches new features for bioinformatics solutions Qiagen has announced the introduction of expanded functionality for its range of bioinformatics workflow solutions.… Super User 0 Love0
News October 24, 2014 Predictive Medicine Depends on Analytics – Harvard Business Review Regression models, Monte Carlo simulations, and other methods for predicting what’s around the corner have… Super User 0 Love0
News October 24, 2014 Roche outlines $3bn expansion for its Basel site – PMLiVE Roche plans to spend around $3bn updating and expanding its Basal site, home to the… Super User 0 Love0
News October 24, 2014 HHS Secretary announces $840 million initiative to improve patient care and lower costs New initiative will support networks that help doctors access information and improve health outcomes Health… Super User 0 Love0
News October 24, 2014 Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone) Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda Pharmaceutical Company Limited (Takeda)… Super User 0 Love0
News October 23, 2014 5 charts illustrate the “evolve or die” crisis facing the medical device industry It’s not just the FDA that is making life difficult for medical device companies. Executives… Super User 0 Love0
News October 23, 2014 Surgeons, say goodbye to stitches or staples – ZipLine has an alternative Stapling up skin post-surgery is pretty much the norm to quickly seal up wounds, but it runs… Super User 0 Love0
News October 23, 2014 How a Univ. of Md. policy will help non-tenure faculty land promotions – The Diamondback : News Colleen Worthington has been working at this university for more than 24 years. It wasn’t… Super User 0 Love0
News October 23, 2014 Health department launches TB trial with emocha app – Technical.ly Baltimore Tuberculosis is both tough to treat and medically cumbersome to manage. Under directly observed therapy,… Super User 0 Love0
News October 22, 2014 Army awards Baltimore’s Profectus BioSciences $8.5M for Ebola vaccine work – Baltimore Business Journal Baltimore biopharmaceutical company Profectus BioSciences Inc. has received a three-year, $8.5 million grant from the… Super User 0 Love0